Purpose: Our objective was to evaluate the effect of the calcium (Ca2+) cha
nnel blocking agent nifedipine on bladder overactivity induced by middle ce
rebral artery (MCA) occlusion and determine its site of action.
Materials and Methods: Seven days after implantation of a bladder catheter,
a cannula for intracerebroventricular and intrathecal administration was i
mplanted and the left MCA was occluded with 4-0 monofilament nylon thread i
n male SD rats. Twenty-four hours after the induction of cerebral ischemia,
saline was infused into the bladder at a constant rate (200 mu L/min.) and
cystometrogram was measured in conscious state. Nifedipine was administere
d intracerebroventricularly (5 mu L) or intrathecally (20 mu L) at graded d
oses (0.15 ng.-0.15 mu g., 0.15 mu g. -1.5 mu g., respectively).
Results: Bladder capacity in conscious rats was significantly reduced after
the left MCA occlusion. Intracerebroventricular administration of nifedipi
ne significantly increased bladder capacity in cerebral infarcted rats but
not in sham operated rats. Furthermore there was no significant difference
in bladder capacity between before and after intrathecal administration of
nifedipine in cerebral infarcted rats.
Conclusion: These results show that Ca2+ channel blocking agents can operat
e especially on the supraspinal central nervous system rather than on the s
pinal system in rats with neurogenic bladder overactivity following: cerebr
al infarction.